Infant botulism in the age of botulism immune globulin

Infant botulism causes acute bulbar dysfunction, weakness, and respiratory failure in infants living in endemic regions of the United States. Until Food and Drug Administration approval of botulism immune globulin (BIG) in October 2003, management of infant botulism had changed little since the 1970...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurology 2005-06, Vol.64 (12), p.2029-2032
Hauptverfasser:	Thompson, J A, Filloux, F M, Van Orman, C B, Swoboda, K, Peterson, P, Firth, S D, Bale, Jr, J F
Format:	Artikel
Sprache:	eng
Schlagworte:	Botulism - drug therapy Botulism - epidemiology Botulism - physiopathology Clostridium botulinum Environmental Exposure - statistics & numerical data Feeding Methods - statistics & numerical data Female Gastrointestinal Tract - microbiology Gastrointestinal Tract - physiopathology Hospitalization - statistics & numerical data Humans Immunoglobulins - therapeutic use Immunoglobulins, Intravenous - therapeutic use Infant Length of Stay Male United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!